Abstract:Introduction: Angiotensin II Type 1 receptor (AT1R) is a member of the G protein-coupled receptors (GPCRs) family, playing an important role in several cardiovascular diseases. Depending on the stimulus, AT1R activates a cascade of signaling pathways including those mediated by G proteins and the multifunctional proteins β-arrestins. AT1R is also mechanosensor and respond to membrane stretch by activating ligand-independent β-arrestin-biased signaling. Objective: The aim of this study is to investigate the precise molecular mechanism for mechanoactivation of the AT1R. Methods and Results: Our previous work demonstrated that mechanical stretch induced by hypotonicity (osmotic-stretch, OSM) allosterically activates the AT1R to mediate β-arrestin signaling. Using Proximity Ligation Assays (PLA) and co-IP we now demonstrate that OSM uniquely promotes Gαi recruitment to AT1R to initiate β-arrestin signaling. In sharp contrast to the β-arrestin-biased ligand TRV120023, the Gαi inhibitor Pertussis Toxin (PTX) blocked the OSM-induced β-arrestin recruitment, EGFR transactivation and ERK signaling. To determine whether the two biased stimuli (OSM and TRV120023) can activate different β-arrestin conformations, we used β-arrestin FLAsH constructs and monitored BRET following AT1R activation by either ligand or stretch stimulation. A FlAsH constructs located in the N-domain domain and two located in the C-domain domain showed a distinct BRET pattern indicating that in response to OSM, β-arrestin assumes a distinct conformation from either the balanced ligand Angiontensin II and the TRV120023 (N=7; p<0.05). Current studies are underway using site-specific stable-isotope labeling strategies coupled with mass spectrometry-based quantitative analysis (CDSiL-MS) to obtain biophysical information regarding the precise AT1R conformations induced by these balanced and β-arrestin-biased stimuli. Conclusion: The principal driver for differential signaling is thought to be different receptor conformations stabilized by each ligand. Our data suggest that in response to two β-arrestin-biased stimuli, AT1R likely adopt distinct conformations indicating remarkable conformational heterogeneity in activating intracellular responses.

Structural Insights into Ligand Recognition and Activation of Angiotensin Receptors.

Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Structural basis for selectivity and diversity in angiotensin II receptors

Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography

The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure

Angiotensin II Enhances Group 2 Innate Lymphoid Cell Responses Via AT1a During Airway Inflammation.

Abstract 315: Mechanical Stretch Activates Biased AT1R Signaling and a Distinct Β-Arrestin Conformation

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanisms

Implications of β-Arrestin biased signaling by angiotensin II type 1 receptor for cardiovascular drug discovery and therapeutics

Single-molecule Force Spectroscopy Study of Interactions Between Angiotensin II Type 1 Receptor and Different Biased Ligands in Living Cells

Label-free cell signaling pathway deconvolution of Angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIII\IV responses

Insights into the Activation and Inhibition of Angiotensin Ii Type 1 Receptor in the Mechanically Loaded Heart

Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling

Activation Pathway of a G Protein-Coupled Receptor Uncovers Conformational Intermediates As Targets for Allosteric Drug Design

Unraveling the crosstalk between renin‐angiotensin system receptors

Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting

Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists

Structural Rearrangement of the AT1 Receptor Modulated by Membrane Thickness and Tension